Amgen Inc. Share | Buy US Stock from India on Kuvera

Q: Can I buy Amgen Inc. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Amgen Inc. stocks after a simple registration process. </div>

Q: How to buy Amgen Inc. shares in India?

<div> To buy Amgen Inc. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Amgen Inc. and you are done!</div> </div>

Q: What is the share price of Amgen Inc.?

<div>The share price of Amgen Inc. is USD 278.39 as on 2 May.</div>

Q: What is the Market Capitalization of Amgen Inc.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Amgen Inc. is USD 149.32B as on 2 May.</div>

Q: What is the PE ratio of Amgen Inc.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Amgen Inc. is 22.15 as on 2 May. </div>

Q: Is Amgen Inc. a good stock to buy?

<div>Kuvera provides relevant fundamental details of Amgen Inc. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Amgen Inc. operate?

<div> Amgen Inc. operates in Healthcare / Drug manufacturers - general

Healthcare Drug manufacturers - general

$278.39

+1.03

(2 May)

Loading Chart

Previous close

$278.39

Open

$278.39

Today’s high

$278.63

Today’s low

$274.90

52W low

$211.71

52W high

$329.72

21.88%

12.93%

22.15

Div yield

3.05%

EPS (TTM)

12.49

Dividend

8.46

Shares O/S

536.38M

Market cap

149.32B

Insights

AMGN price is above its 200 day moving average

In beta. Send feedback here.

Compare with other stock

About Amgen Inc.

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine), KYPROLIS (carfilzomib), Maridebart cafraglutide, (infliximab-axxq), Evenity, LumaKras, Nplate and XGeva, others.

FAQs

Can I buy Amgen Inc. shares in India?

How to buy Amgen Inc. shares in India?

What is the share price of Amgen Inc.?

What is the Market Capitalization of Amgen Inc.?

What is the PE ratio of Amgen Inc.?

Is Amgen Inc. a good stock to buy?

In which sector / industry does Amgen Inc. operate?